Flumazenil Injection, Solution
Product Images NDC 0404-9794

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Flumazenil (NDC 0404-9794). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Formula1.jpg (Formula1)
Chemical structure of flumazenil, the active ingredient in FLUMAZENIL injection solution. The structure shows a fluorinated benzodiazepine derivative with an imidazole ring and ester functional groups.*
FDA Label Image

Image1.jpg (Image1)

Image1.jpg (Image1)
A graph showing the magnitude and duration of reversal of sedation by flumazenil at doses of 0.2 mg, 0.6 mg, and 1 mg, represented by alertness levels over time in minutes after flumazenil intravenous injection. The y-axis indicates levels from sedated to completely alert, and the chart includes blood levels in ng/mL. The data is based on sedation from midazolam infusion in healthy volunteers.*
FDA Label Image

Image2.jpg (Image2)

Image2.jpg (Image2)
A data table presenting pharmacokinetic parameters including Cmax (ng/mL), AUC (ng·hr/mL), Vss (L/kg), Cl (L/hr/kg), and half-life (minutes) with their respective values and variability ranges.*
FDA Label Image

Image3.jpg (Image3)

Image3.jpg (Image3)
A text panel warning about the association of flumazenil use with seizures, particularly in patients with long-term benzodiazepine use or serious cyclic antidepressant overdose. It advises practitioners to individualize flumazenil dosage and be prepared to manage seizures.*
FDA Label Image

Label1.jpg (Label1)

Label1.jpg (Label1)
Label for Flumazenil injection, 0.1 mg/mL strength in a 10 mL multiple dose vial. The label indicates the product is for intravenous use only, sterile, and should be stored at controlled room temperature. It provides storage instructions, manufacturer information for Henry Schein, Inc., and an NDC barcode for product identification.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.